Posterior Reversible Encephalopathy Syndrome in a Woman With Behcet’s Disease: Case Report

Itxaso Azkune-Calle, Ana Pinedo-Brochado, Alberto Cabrera-Zubizarreta, Inigo Vicente-Olabarria, Juan Carlos Garcia-Monco

Abstract


Posterior reversible encephalopathy syndrome (PRES) is an entity characterized by the presence of variable neurological symptoms and reversible edema typically affecting the posterior white matter on brain MRI studies. It has been described in association with autoimmune diseases and with the use of chemotherapy and immunosuppressive drugs. We report a case of a 58-year-old woman with Behcet’s disease treated with methotrexate, adalimumab and low-dose prednisone who presented with sudden bilateral visual loss, together with radiological findings and clinical course suggesting PRES. PRES may appear associated with Behcet’s disease, from whose neurological complications should be differentiated, since management and prognosis differ significantly.




J Med Cases. 2014;5(3):177-179
doi: http://dx.doi.org/10.14740/jmc1442w

Keywords


Posterior reversible encephalopathy syndrome; PRES; Reversible posterior leukoencephalopathy syndrome; RPLS; Hypertensive encephalopathy; Behcet’s disease

Full Text: HTML PDF
 

Browse  Journals  

     

Journal of clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 

 

 

 

Journal of Medical Cases, monthly, ISSN 1923-4155 (print), 1923-4163 (online), published by Elmer Press Inc.            
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.journalmc.org   editorial contact: editor@journalmc.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.